Efficacy and Safety Study of Meloxicam Nanocrystal Injection for the Treatment of Moderate to Severe Pain

Conditions: Pain Interventions: Drug: Meloxicam Nanocrystal Injection; Drug: Placebo Sponsors: CSPC ZhongQi Pharmaceutical Technology Co., Ltd. Completed

https://clinicaltrials.gov/study/NCT06379165

Source: ClinicalTrials.gov - April 23, 2024 Category: Research Source Type: clinical trials